Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
TRVI
Stock Latest News
The Fly
Trevi Therapeutics management to meet virtually with B. Riley
5d ago
TRVI
Premium
The Fly
Trevi Therapeutics management to meet with Cantor Fitzgerald
15d ago
TRVI
Premium
Ratings
Trevi Therapeutics’ Haduvio: A Promising Therapy for IPF and RCC with Anticipated CORAL Trial Results
18d ago
TRVI
Premium
Company Announcements
Trevi Therapeutics’ Earnings Call: Clinical Success Amid Financial Challenges
1M ago
TRVI
Premium
Market News
Trevi Therapeutics Stock (TRVI) Surges Over 60% on Promising Trial Results and Q4 Financials
1M ago
TRVI
Premium
The Fly
Trevi Therapeutics price target raised to $20 from $11 at B. Riley
1M ago
TRVI
Premium
Ratings
Trevi Therapeutics’ Promising Prospects: Buy Rating Backed by Positive Trial Results and Market Potential
1M ago
TRVI
Premium
Ratings
Trevi Therapeutics’ Haduvio: Promising Developments and Strategic Advancements Reinforce Buy Rating
1M ago
TRVI
Premium
Ratings
Trevi Therapeutics: Buy Rating Backed by Promising Haduvio Trial Results and Strong Market Potential
1M ago
TRVI
Premium
Company Announcements
Trevi Therapeutics Advances Haduvio in Clinical Trials
1M ago
TRVI
Premium
The Fly
Trevi Therapeutics reports Q4 EPS (11c), consensus (12c)
1M ago
TRVI
Premium
The Fly
Trevi Therapeutics options imply 7.8% move in share price post-earnings
1M ago
TRVI
Premium
The Fly
Trevi Therapeutics added to Analyst Current Favorites list at Raymond James
1M ago
TRVI
Premium
Ratings
Trevi Therapeutics: Buy Rating Amid Promising Haduvio Trial Prospects and Strong Market Potential
1M ago
TRVI
Premium
Pre-Earnings
Trevi Therapeutics (TRVI) Q4 Earnings Cheat Sheet
1M ago
TRVI
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
WW
FRO
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
AEON
APRE
Premium
The Fly
Trevi Therapeutics price target raised to $20 from $12 at Oppenheimer
2M ago
TRVI
Premium
The Fly
Trevi Therapeutics price target raised to $12.50 from $7.50 at H.C. Wainwright
2M ago
TRVI
Premium
Ratings
Haduvio’s Promising Efficacy in RCC Drives Buy Rating and Increased Price Target
2M ago
TRVI
Premium
The Fly
Trevi Therapeutics price target raised to $11 from $7 at Leerink
2M ago
TRVI
Premium
The Fly
Trevi Therapeutics price target raised to $25 from $8 at Needham
2M ago
TRVI
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
